FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a new crystalline modification A of hydrochloride (-)-(1R, 2R)-3-(3-dimethylamino-1-ethyl-2-methylpropiyl)phenol having at least characteristic lines in X-ray powder diffractogram presented with using Cu Kα-radiation with the values of a 2-teta angle making 15.1±0.2, 16.0±0.2, 18.9±0.2, 20.4±0.2, 22.5+0.2, 27.3±0.2, 29.3±0.2 and 30.4±0.2. An elementary cell of said modification usually has a monoclinic structure. According to the present invention, the crystalline modification A of said compound is produced, e.g. by dissolving hydrochloride (-)-(1R, 2R)-3 (3-dimethylamino-1-ethyl-2-methylpropyl)phenol in the form of the crystalline modification B in acetone or acetonitrile at temperature more than +40°C or in isopropanol at temperature more than +65°C, but not exceeding 80°C, keeping a crystallisation solution and recovering the crystals of hydrochloride (-)-(1R, 2R)-3 (3-dimethylamino-1-ethyl-2-methylpropyl)phenol in the form of the crystalline modification A.
EFFECT: preparation of a drug for pain management or enuresis treatment.
15 cl, 4 tbl, 15 ex
Title |
Year |
Author |
Number |
3-[2-(DIMETHYLAMINO)METHYL-(CYCLOHEX-1-YL)]PHENOL MALEATE AND ITS CRYSTALLINE FORMS |
2006 |
- Gruss Mikhaehl'
- Khell' Vol'Fgang
- Shelagevich Martin
- Bergkhauzen Jern
- Di-Pol S'Jusan Margaret
- Fon-Raumer Markus
|
RU2434845C2 |
PHARMACEUTICAL COMBINATION CONTAINING 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)PHENOL AND NON-STEROID ANTI-INFLAMMATORY PREPARATION |
2007 |
- Shine Klaus
- Bloms-Funke Petra
|
RU2465263C2 |
MEDICINE CONTAINING 3-(3-DIMETHYLAMINE-1-ETHYL-2-METHYLPROPYL) PHENOL WITH PROLONGED RELEASE OF REACTANT |
2002 |
- Bartolomeus Iogannes
- Tsigler Iris
|
RU2325905C2 |
PHARMACEUTICAL COMBINATIONS CONTAINING 3-(3-DIMETHYLAMIN-1-ETHYL-2-METHYLPROPYL)-PHENOL AND PARACETAMOL |
2007 |
- Bloms-Funke Petra
- Shine Klaus
|
RU2442576C2 |
PRODUCING 3-[(1R,2R)-3-(DIMETHYLAMINO)-1-ETHYL-2-METHYLPROPYL]-PHENOL |
2007 |
|
RU2463290C2 |
NOVEL CRYSTALLINE FORM OF (3-CYANO-1N-INDOL-7-YL)-[4-(4-FLUOROPHENETHYL)PIPERAZIN-1-YL]METHANONE HYDROCHLORIDE |
2005 |
- Bate Andreas
- Khel'Fert Bernd
- Knirime Ral'F
- Zal Kristof
- Kajner Ronal'D
|
RU2383532C2 |
NOVEL CRYSTALLINE FORMS OF N-[-2[[(2,3-DIFLUOROPHENYL)METHYL]THIO]-6-{[(1R,2S)-2,3-DIHYDROXY-1-METHYLPROPYL]OXY}-4-PYRIMIDINYL]-1-AZATIDINE-SULPHONAMIDE |
2011 |
- Gullberg Britt Anne Ingela
- Larsson Peter Thomas
- Stonehouse Jeffrey Paul
|
RU2548044C2 |
METHOD OF PRODUCING SUBSTITUTED 3-ARYLBUTYLAMINE COMPOUNDS |
2004 |
- Khell' Vol'Fgang
- Kegel' Markus
- Akteris Bernkhard
- Bushmann Khel'Mut
- Kholents Jerg
- Lebermann Khartmut
- Kheller Detlef
- Dreksler Khans-Joakhim
- Gladov Shtefan
|
RU2380355C2 |
TRIAZINE DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST VIRUS REPLICATION, AND PHARMACEUTICAL COMPOSITION CONTAINING THEM |
2022 |
- Tachibana Yuki
- Uehara Shota
- Unoh Yuto
- Nakahara Kenji
- Taoda Yoshiyuki
- Yamatsu Yukiko
- Ando Shigeru
- Sasaki Michihito
|
RU2806042C1 |
SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-cd]INDOL-6-ONE |
2011 |
- Patrishija Ehnn Basford
- Antoni Majkl Kampeta
- Adam Dzhillmor
- Matt'Ju Kameron Dzhons
- Ehlefterois Kougoulos
- Suman Lutra
- Robert Uolton
|
RU2570198C2 |